Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 28, 2022

Investigational Drug Information for Ataciguat

✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Ataciguat?

Ataciguat is an investigational drug.

There have been 4 clinical trials for Ataciguat. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1^st 2008.

The most common disease conditions in clinical trials are Constriction, Pathologic, Aortic Valve Stenosis, and Intermittent Claudication. The leading clinical trial sponsors are Sanofi, National Center for Advancing Translational Science (NCATS), and National Center for Research Resources (NCRR).

Summary for Ataciguat

US Patents	0
International Patents	0
US Patent Applications	271
WIPO Patent Applications	106
Japanese Patent Applications	20
Clinical Trial Progress	Phase 2 (2008-11-01)
Vendors	29

Recent Clinical Trials for Ataciguat

Title	Sponsor	Phase
A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification	National Institutes of Health (NIH)	Phase 2
A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification	Sanofi	Phase 2
A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification	Mayo Clinic	Phase 2

See all Ataciguat clinical trials

Clinical Trial Summary for Ataciguat

Top disease conditions for Ataciguat

Top clinical trial sponsors for Ataciguat

See all Ataciguat clinical trials

US Patents for Ataciguat

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Harvard Business School

Medtronic

McKesson

Express Scripts

Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.